Table 2.
Steps | Factors/Processes | Mechanisms | References |
---|---|---|---|
Exosome absorption | |||
Exosome biodistribution and organ-specific accumulation | Retention in lymph nodes and bone | Exosome size | [14] |
Route of administration | Intratumoral, intravenous, etc. | [99,100,101] | |
Cell type-specific rate of exosome uptake | Cell type-dependent factors | [102] | |
Targeting to recipient cell | Receptor–ligand interaction | RVG, SDF-1; integrins (αvβ5, α6β4, α6β1, α4β7), TSPNs (TSPAN8, CD63), CD47 | [103,104,105] [112,113,114,115,116] |
Lipid targeting | Phosphatidylethanolamine, sphingomyelin | [106,107] | |
Cell-type-specific exosome uptake | Recognition moieties from the donor cell type | [108,109,110,111] | |
Recipient cell interactions | Signal transduction via receptors | MHC-peptide complex, TNF receptors | [118,119] |
Membrane fusion | Rabs, SNARE; membrane rigidity and lipid content | [107,122] | |
Clathrin-mediated endocytosis | Dynamin-2; transferrin | [117,124,125] | |
Lipid raft endocytosis | Cholesterol, sphingolipid, flotillin | [126,127,128,129] | |
Macropinocytosis | Rac1 GTPase, actin, cholesterol, EGFR | [130,131,132] | |
Caveolin-dependent endocytosis | Caveolin-1 | [133,134] | |
Phagocytosis | PI3K, phosphatidylserine | [125,135,136,137,138] | |
Internalized exosomes | Lysosomal degradation | Trafficking to lysosomes (e.g., Rab7) | [80,139] |
Bypassing lysosomal degradation | Passive diffusion; cargo activation by acidification; RNA transfer to ER; fusion with endosomal membrane (e.g., LBPA) | [108,140,141,142,143] | |
Re-release | Sorting to recycling endosomes | [144,145] |
Abbreviations: RVG, rabies viral glycoprotein; TSPN, tetraspanin; ER, endoplasmic reticulum; LBPA, lysobisphosphatidic acid.